New York State Common Retirement Fund’s Protara Therapeutics TARA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.2K Hold
7,900
﹤0.01% 3086
2026
Q1
$41.2K Sell
7,900
-7,100
-47% -$42K ﹤0.01% 2873
2025
Q4
$80K Sell
15,000
-4,700
-24% -$26.1K ﹤0.01% 2714
2025
Q3
$85.7K Sell
19,700
-13,900
-41% -$45K ﹤0.01% 2699
2025
Q2
$102K Buy
+33,600
New +$116K ﹤0.01% 2630
2021
Q3
Sell
-29
Closed 3515
2021
Q2
$0 Sell
29
-3,171
-99% -$35.9K ﹤0.01% 3571
2021
Q1
$50K Hold
3,200
﹤0.01% 3221
2020
Q4
$77K Hold
3,200
﹤0.01% 3117
2020
Q3
$54K Hold
3,200
﹤0.01% 3124
2020
Q2
$94K Buy
+3,200
New +$99.1K ﹤0.01% 3005
2016
Q2
Sell
-178
Closed -$55K 3207
2016
Q1
$55K Hold
178
﹤0.01% 3044
2015
Q4
$110K Hold
178
﹤0.01% 2986
2015
Q3
$99K Buy
178
+133
+296% +$82.4K ﹤0.01% 3033
2015
Q2
$32K Buy
+45
New +$27.8K ﹤0.01% 3249

Other funds holding TARA

New York State Common Retirement Fund's TARA Position: Q2 2026 in Review

New York State Common Retirement Fund held its Protara Therapeutics (TARA) position steady in Q2 2026 at 7,900 shares worth $30.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3086.

New York State Common Retirement Fund first reported a position in TARA in Q2 2015 and has held it in 14 quarters since. The position peaked at $110K in Q4 2015. 19 funds tracked by Wall St. Rank hold TARA as of Q2 2026.

  • New York State Common Retirement Fund held 7,900 shares of Protara Therapeutics worth $30.2K as of Q2 2026.
  • New York State Common Retirement Fund left its Protara Therapeutics share count unchanged in Q2 2026.
  • Protara Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #3086 holding.
  • New York State Common Retirement Fund first reported a position in Protara Therapeutics in Q2 2015 and has held it in 14 quarters since.
  • New York State Common Retirement Fund's Protara Therapeutics position peaked at $110K in Q4 2015.
  • 19 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.